Condition
Severe Alopecia Areata clinical trials and research
Research outlook What's coming for Alopecia areata: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Severe Alopecia Areata clinical trials that are recruiting, at sites in 12 countries (most in China (2), Japan (2), United States (2)). By phase: Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 12Countries
Newest Severe Alopecia Areata clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Upadacitinib for Severe Alopecia Areata in Children | Phase 3 | Los Angeles, California and 13 other locations | Recruiting | Aug 19, 2026 |
| Safety and body handling of IBI3013 after single and multiple doses in healthy adults and men with active non-segmental vitiligo or severe alopecia areata | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Apr 28, 2026 |
| Litfulo capsule for people with severe alopecia areata in routine care | — | Seoul | Recruiting | Sep 3, 2025 |
| Long-term ritlecitinib treatment for children with severe alopecia areata | Phase 3 | Irvine, California and 66 other locations | Recruiting | Jun 19, 2025 |
All recruiting trials (4)
-
Upadacitinib for Severe Alopecia Areata in Children
This study tests whether upadacitinib can safely help children with severe alopecia areata grow back hair, compared with placebo.
-
Safety and body handling of IBI3013 after single and multiple doses in healthy adults and men with active non-segmental vitiligo or severe alopecia areata
This trial tests whether IBI3013 is safe and how the body processes it in healthy adults and in men with active non-segmental vitiligo or severe alopecia areata.
-
Litfulo capsule for people with severe alopecia areata in routine care
People aged 12 and older with severe alopecia areata who start Litfulo capsules will be followed in routine clinics to see if the medicine is safe and what effects it has.
-
Long-term ritlecitinib treatment for children with severe alopecia areata
This study will give ritlecitinib to children who completed earlier Pfizer pediatric ritlecitinib studies to see if long-term treatment is safe and helps maintain or improve hair regrowth.
Related topics
Quick answers
How many Severe Alopecia Areata clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in China (2 trials), Japan (2 trials), United States (2 trials), Czechia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.